Ybrain Demonstrates Cognitive Function Improvement in Stroke Patients... Published in Prestigious International Journal

[Asia Economy Reporter Hyungsoo Park] NeoFact's affiliate Ybrain announced on the 19th that a research paper on the transcranial direct current stimulation (tDCS) electronic medicine 'MINDD STIM,' developed in-house, was published in Stroke, a world-renowned journal in the field of stroke.

The research was conducted by Professor Yeonhee Kim's team from the Department of Rehabilitation Medicine at Samsung Seoul Hospital and Professor Myunghwan Ko's team from the Department of Rehabilitation Medicine at Jeonbuk National University. They analyzed the effects of cognitive therapy using NeoFact's first domestic computer-based cognitive rehabilitation program ComCog and Ybrain's MINDD STIM on improving cognitive function in chronic stroke patients.

A clinical trial was conducted on 26 patients with chronic stroke and cognitive impairment. The patients were divided into two groups and underwent 20 sessions of rehabilitation training, 30 minutes daily for 4 weeks. The evaluation methods used to measure the results included the Korean version of the Montreal Cognitive Assessment (K-MoCA), the Korean version of the Dementia Rating Scale (K-DRS), and the Korean version of the Boston Naming Test (K-BNT).

The clinical trial results showed that the group wearing MINDD STIM and undergoing ComCog rehabilitation training had higher Montreal Cognitive Assessment scores. Significant therapeutic effects were observed in patients with moderate cognitive impairment and left hemisphere lesions.

Since patients received MINDD STIM prescriptions remotely at home and conducted the training, the safety and convenience of home-based remote cognitive rehabilitation training were also confirmed.

A NeoFact representative stated, "It is meaningful that we have further demonstrated the efficacy and safety of electronic medicine in improving cognitive function, not only for depression but also for other conditions," adding, "We will do our best to obtain approval for electronic medicine for treating not only brain disease patients but also dementia patients."

This content was produced with the assistance of AI translation services.